Celcuity (CELC) News Today → Read this before you buy AI stocks (From InvestorPlace) (Ad) Free CELC Stock Alerts $16.80 +0.04 (+0.24%) (As of 04:00 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 20 at 5:34 AM | americanbankingnews.comCelcuity (NASDAQ:CELC) Stock Rating Reaffirmed by Needham & Company LLCMay 20 at 2:04 AM | americanbankingnews.comCelcuity Inc. (NASDAQ:CELC) Forecasted to Post Q2 2024 Earnings of ($0.74) Per ShareMay 19 at 8:59 AM | americanbankingnews.comStifel Nicolaus Reaffirms "Buy" Rating for Celcuity (NASDAQ:CELC)May 19 at 6:22 AM | americanbankingnews.comCelcuity (NASDAQ:CELC) Trading Down 4.6%May 19 at 3:30 AM | americanbankingnews.comFY2028 Earnings Estimate for Celcuity Inc. (NASDAQ:CELC) Issued By HC WainwrightMay 18 at 5:36 AM | americanbankingnews.comCelcuity (NASDAQ:CELC) Stock Rating Reaffirmed by Craig HallumMay 18 at 5:36 AM | americanbankingnews.comCelcuity (NASDAQ:CELC) Rating Reiterated by HC WainwrightMay 17 at 3:52 PM | marketbeat.comCelcuity (NASDAQ:CELC) Shares Down 4.6% Celcuity (NASDAQ:CELC) Shares Down 4.6%May 17 at 10:10 AM | marketbeat.comHC Wainwright Equities Analysts Decrease Earnings Estimates for Celcuity Inc. (NASDAQ:CELC)Celcuity Inc. (NASDAQ:CELC - Free Report) - Stock analysts at HC Wainwright lowered their FY2028 earnings per share (EPS) estimates for shares of Celcuity in a research note issued to investors on Thursday, May 16th. HC Wainwright analyst S. Ramakanth now expects that the company will post earninMay 16, 2024 | markets.businessinsider.comGrowth Potential Drives Buy Rating for Celcuity Despite Current LossesMay 16, 2024 | markets.businessinsider.comCelcuity’s Clinical and Financial Momentum Justifies Buy Rating and $24 Price TargetMay 16, 2024 | msn.comCelcuity Inc. (NASDAQ:CELC) Q1 2024 Earnings Call TranscriptMay 16, 2024 | marketbeat.comCelcuity's (CELC) "Buy" Rating Reaffirmed at Stifel NicolausStifel Nicolaus restated a "buy" rating and set a $40.00 target price on shares of Celcuity in a research report on Thursday.May 16, 2024 | marketbeat.comCelcuity (NASDAQ:CELC) Shares Gap Up to $17.23Celcuity (NASDAQ:CELC) Shares Gap Up to $17.23May 16, 2024 | finance.yahoo.comCelcuity Inc (CELC) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges and ...May 15, 2024 | msn.comCelcuity Non-GAAP EPS of -$0.59May 15, 2024 | globenewswire.comCelcuity Inc. Reports First Quarter Financial Results and Provides Corporate UpdateMay 13, 2024 | americanbankingnews.comCelcuity (CELC) to Announce Quarterly Earnings on WednesdayMay 9, 2024 | marketbeat.comCelcuity (CELC) Set to Announce Quarterly Earnings on WednesdayCelcuity (NASDAQ:CELC) will be releasing earnings after the market closes on Wednesday, May 15, Zacks reports.May 9, 2024 | marketbeat.comCelcuity (NASDAQ:CELC) Trading Down 0.5%Celcuity (NASDAQ:CELC) Shares Down 0.5%May 8, 2024 | globenewswire.comCelcuity Inc. Schedules Release of First Quarter 2024 Financial Results and Webcast/Conference CallMay 3, 2024 | finanznachrichten.deUSA News Group: Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032April 28, 2024 | investing.comCelcuity director Richard E. Buller sells $5,971 in stockApril 16, 2024 | marketbeat.comShort Interest in Celcuity Inc. (NASDAQ:CELC) Drops By 7.5%Celcuity Inc. (NASDAQ:CELC - Get Free Report) was the target of a large drop in short interest in March. As of March 31st, there was short interest totalling 1,860,000 shares, a drop of 7.5% from the March 15th total of 2,010,000 shares. Based on an average daily volume of 230,800 shares, the days-to-cover ratio is presently 8.1 days.April 12, 2024 | marketbeat.comCelcuity (NASDAQ:CELC) Given Buy Rating at Needham & Company LLCNeedham & Company LLC restated a "buy" rating and set a $24.00 price target on shares of Celcuity in a research report on Friday.April 8, 2024 | marketbeat.comCelcuity (NASDAQ:CELC) Stock Price Down 3.6%Celcuity (NASDAQ:CELC) Trading Down 3.6%April 4, 2024 | marketbeat.comCelcuity (NASDAQ:CELC) Shares Up 4.5%Celcuity (NASDAQ:CELC) Shares Up 4.5%April 4, 2024 | globenewswire.comCelcuity To Present at Upcoming Needham and Stifel Investor ConferencesApril 3, 2024 | msn.comCelcuity (NASDAQ:CELC): A Biotech with Blockbuster PotentialApril 3, 2024 | finance.yahoo.comCelcuity Gains 12%, Insider Trades Reap BenefitApril 1, 2024 | finance.yahoo.comCelcuity Inc. (NASDAQ:CELC) Q4 2023 Earnings Call TranscriptMarch 30, 2024 | msn.comI Gave Birth At A US Hospital In 2023 — Let's Break Down My $65,000 BillMarch 30, 2024 | msn.comOne dead, another in ICU after drug overdoseMarch 29, 2024 | markets.businessinsider.comGedatolisib’s Promising Clinical Trial Performance and Market Potential Justify Buy RatingMarch 28, 2024 | marketbeat.comCelcuity (NASDAQ:CELC) Price Target Raised to $25.00Craig Hallum raised their price objective on shares of Celcuity from $20.00 to $25.00 and gave the stock a "buy" rating in a report on Thursday.March 28, 2024 | marketbeat.comCelcuity (NASDAQ:CELC) Reaches New 1-Year High After Analyst UpgradeCelcuity (NASDAQ:CELC) Reaches New 12-Month High Following Analyst UpgradeMarch 28, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Celcuity (CELC), Cara Therapeutics (CARA)March 28, 2024 | finance.yahoo.comQ4 2023 Celcuity Inc Earnings CallMarch 28, 2024 | marketbeat.comCelcuity's (CELC) "Buy" Rating Reiterated at HC WainwrightHC Wainwright reissued a "buy" rating and issued a $27.00 price objective on shares of Celcuity in a research note on Thursday.March 27, 2024 | finance.yahoo.comCelcuity Inc (CELC) Reports Full Year 2023 Financial Results and Highlights Key DevelopmentsMarch 27, 2024 | benzinga.comRecap: Celcuity Q4 EarningsMarch 27, 2024 | globenewswire.comCelcuity Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateMarch 20, 2024 | marketbeat.comCelcuity (CELC) Scheduled to Post Quarterly Earnings on ThursdayCelcuity (NASDAQ:CELC) will be releasing earnings on Thursday, March 21, Yahoo Finance reports.March 20, 2024 | globenewswire.comCelcuity Inc. Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Webcast/Conference CallMarch 16, 2024 | marketbeat.comCelcuity Inc. (NASDAQ:CELC) Sees Significant Growth in Short InterestCelcuity Inc. (NASDAQ:CELC - Get Free Report) was the recipient of a large growth in short interest in February. As of February 29th, there was short interest totalling 2,030,000 shares, a growth of 14.0% from the February 14th total of 1,780,000 shares. Based on an average trading volume of 164,700 shares, the short-interest ratio is presently 12.3 days.March 15, 2024 | finance.yahoo.comCELC Apr 2024 20.000 callMarch 6, 2024 | globenewswire.comCelcuity to Participate in Leerink Partners Global Biopharma Conference 2024February 28, 2024 | finance.yahoo.comCelcuity to Participate in Cowen’s 44th Annual Health Care ConferenceFebruary 28, 2024 | globenewswire.comCelcuity to Participate in Cowen's 44th Annual Health Care ConferenceFebruary 25, 2024 | msn.comCelcuity (CELC) Price Target Increased by 12.99% to 27.95 Get Celcuity News Delivered to You Automatically Sign up to receive the latest news and ratings for CELC and its competitors with MarketBeat's FREE daily newsletter. Email Address Read this before you buy AI stocks (Ad)BREAKING: New "Formula" Could Lead to Huge AI Payouts When you click here and see what Elon Musk's new invention does… Investors — including multiple billionaires — are now tapping into a unique AI secret to pocket huge, consistent payouts. Starting today, you could siphon a new stream of income from this $3 billion pool of cash. CELC Media Mentions By Week CELC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CELC News Sentiment▼0.230.42▲Average Medical News Sentiment CELC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CELC Articles This Week▼261▲CELC Articles Average Week Get Celcuity News Delivered to You Automatically Sign up to receive the latest news and ratings for CELC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Castle Biosciences News Today Fulgent Genetics News Today Sera Prognostics News Today CareDx News Today Biodesix News Today Viridian Therapeutics News Today Enzo Biochem News Today Renalytix News Today Exagen News Today DermTech News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CELC) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDoes this make you sick?Allegiance GoldThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Celcuity Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
